Literature DB >> 4999904

Paradoxical synergism and antagonism between serum and the antibacterial activity of colistin.

S D Davis, A Iannetta, R J Wedgwood.   

Abstract

Mesh:

Substances:

Year:  1971        PMID: 4999904     DOI: 10.1093/infdis/123.4.392

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  8 in total

Review 1.  Principles of combination therapy.

Authors:  S Levin; A A Harris
Journal:  Bull N Y Acad Med       Date:  1975-10

2.  Detection of agents that alter the bacterial cell surface.

Authors:  I Jit Sud; D S Feingold
Journal:  Antimicrob Agents Chemother       Date:  1975-07       Impact factor: 5.191

Review 3.  Seventy-Five Years of Research on Protein Binding.

Authors:  Axel Dalhoff
Journal:  Antimicrob Agents Chemother       Date:  2018-01-25       Impact factor: 5.191

4.  Inactivation of endotoxin by polymyxin B.

Authors:  M S Cooperstock
Journal:  Antimicrob Agents Chemother       Date:  1974-10       Impact factor: 5.191

5.  Influence of serum and calcium on the bactericidal activity of gentamicin and carbenicillin on Pseudomonas aeruginosa.

Authors:  S D Davis; A Iannetta
Journal:  Appl Microbiol       Date:  1972-04

6.  Dissociation between results of in vitro and in vivo antibiotic susceptibility tests for some strains of Pseudomonas aeruginosa.

Authors:  S D Davis
Journal:  Antimicrob Agents Chemother       Date:  1974-03       Impact factor: 5.191

7.  Antagonistic effect of calcium in serum on the activity of tobramycin against Pseudomonas.

Authors:  S D Davis; A Iannetta
Journal:  Antimicrob Agents Chemother       Date:  1972-06       Impact factor: 5.191

8.  Profiling antimicrobial peptides from the medical maggot Lucilia sericata as potential antibiotics for MDR Gram-negative bacteria.

Authors:  Rolf Hirsch; Jochen Wiesner; Alexander Marker; Yvonne Pfeifer; Armin Bauer; Peter E Hammann; Andreas Vilcinskas
Journal:  J Antimicrob Chemother       Date:  2019-01-01       Impact factor: 5.790

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.